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Introduction
• Neuropathic pain can be described as the result of damage caused to the
somatosensory system manifested as a pathological sensitivity to light touch,
clinically referred to as allodynia
• Neuropathic pain is mediated, in part, by cytokines released from activated resident
glial cells and peripheral immune cells that invade the central nervous system
(CNS).
• Our lab has previously demonstrated that prenatal alcohol exposure (PAE) is a risk
factor for developing chronic neuropathic pain from very minor injuries to peripheral
nerves of the somatosensory system that project to and communicate to spinal
pain projection neurons.
• IL-1β is a potent pro-inflammatory cytokine that is elevated in spinal cords and
peripheral immune cells from PAE offspring with either nerve damage or immune
challenge, respectively.
• IL-1β is released by macrophages and to a lesser extent, T cells.
• Dexpramipexole [(+)-pramipexole] is an enantiomer of (-)-pramipexole and has
virtually none of the dopamine receptor binding activity that (-)-pramipexole exerts.
However, given that dexpramipexole reduces caspase-3 activity and cell death, we
speculated that dexpramipexole may exert anti-inflammatory properties on immune
cells and glia.
• Therefore, we tested the hypothesis that administration of dexpramipexole will
result in a decreased inflammatory response and reduced allodynia in PAE
rats
• To test this hypothesis, we administered an intrathecal (i.t., subarachnoid, perispinal) injection of dexpramipexole to determine if spinal glia and local immune
cells could respond to dexpramipxole and lead to reversal of allodynia.
• In addition, we collected immune cells from the spleen (majority T-cells) and
peritoneal cavity (PEC; majority monocytes/macrophages), and stimulated them
with lipopolysaccharide (LPS) alone, or in combination with dexpramipexole to test
whether dexpramipexole can decrease IL-1β protein levels

Methods

Methods (Continued)

i.t. Dexpramipexole in Allodynic Male PAE and Sac Rats

Tissue Collection
Splenocytes were prepared and plated at 0.4 million cells/well. PEC cells
were enriched for macrophages described previously2,3 and plated at 0.3
million cells/well. Both sets of cells were cultured in 24 well tissue culture
plates, and both sets of cells were stimulated for 24 hours with 1ug/ml LPS
and 2ug/ml dexpramipexole. Cells were collected and analyzed for IL-1β
protein content via ELISA assay (R&D Systems).

Results
• In male PAE and SAC rats, robust ipsilateral allodynia occurred on days 3
and 10 following CCI surgery. In PAE rats, this allodynia was reversed 30
minutes after the i.t. injection of dexpramipexole, with hindpaw withdrawal
thresholds returning to normal sensitivity for at least one hour. The allodynia
in SAC rats was reversed 60 minutes after the i.t. injection of dexpramipexole.
Both PAE and SAC rats did not develop contralateral allodynia.
• A mild CCI surgery causes greater sciatic nerve injury and induces robust
allodynia in both SAC and PAE male rats on Days 3 and 10 after CCI.
Figure 1: Intrathecal injection of dexpramipexole reverses allodynia in male Sac and PAE rats. Male Sac and PAE rats subjected to a single
suture CCI develop ipsilateral allodynia 3 days after the CCI, and this allodynia persists through day 10 or 11. Following i.t. dexpramipexole,
allodynia reversal was observed 30 minutes later, with hindpaw threshold responses similar to those of Sham-operated rats. Maximal reversal
occurs at 60 and 90 min in both Sac and PAE rats. Both PAE and Sac male rats fail to develop contralateral allodynia, as predicted. Day 3
interaction p = 0.0215; Day 10 surgery p = 0.0003

• Both splenocytes and PEC cells showed an increase in IL-1β levels following
stimulation with LPS. IL-1β levels were significantly reduced in PEC cells from
PAE offspring following treatment of the cells with LPS in combination with
dexpramipexole. In splenocytes, neither SAC nor PAE cells showed a
decrease in IL-1β levels following treatment with LPS in combination with
dexpramipexole.

IL-1β After Dexpramipexole Treatment in Female PAE and Sac Rats

Prenatal Alcohol Exposure model. Rat dams were provided Sac-sweetened
alcohol (5%) or Sac-sweetened water for 4 hours/day during gestation (BECs:
~60 mg/dl). Offspring were acclimated to a 12:12 light cycle and remained in the
colony room for ~4 months until the time of experimentation.
Habituation and Chronic Constriction Injury (CCI).
Rats were housed in the colony room for 4 months prior to the initiation of
experiments. They were then habituated for a week for an hour a day. Chronic
constriction injury model is a rat model of neuropathic pain based on a unilateral
loose ligation of the sciatic nerve. Chronic constriction injury (CCI) consisted of a
single loose ligation of the left sciatic nerve using (4-0).

Conclusions
•

Both PAE and non-PAE male rats develop allodynia from mild left sciatic nerve
injury.

•

I.t. injection of dexpramipexole reverses allodynia induced by CCI surgery in PAE
and non-PAE male rats.

•

Treatment of PAE and SAC splenocytes and PEC cells with LPS effectively raises
IL-1β expression in splenocytes and PEC cells.

•

Treatment of PEC cells with dexpramipexole is effective in reducing IL-1β following
stimulation with LPS
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Intrathecal (i.t.) injection
On Day 10/11 post-surgery, lightly anesthetized rats received a single i.t. injection
via acute subarachnoid puncture with drug delivered at the spinal level of L5/L6
via a sterile PE-10 catheter threaded 3 cm rostrally.
Behavioral Analysis
Hindpaw withdrawal responses to light touch were assessed using the von Frey
fiber test. Behavior was assessed at baseline (BL) and days 3 and 10 or 11
following CCI for all groups. Rats were reassessed for light touch hindpaw
response at 30, 60, and 90 minutes after the injection. Raw behavioral responses
were then entered into the software program, PsychoFit (L. Harvey, University of
Colorado), to acquire a 50% absolute threshold paw withdrawal response rate
and the data were plotted using GraphPad Prism.

Figure 2: IL-1β levels in splenocytes from female PAE rats were not significantly reduced following stimulation with LPS in combination with
dexpramipexole. However, in PEC cells collected from female rats, a reduction in IL-1β levels was observed following LPS stimulation in
combination with dexpramipexole treatment. Main interaction of LPS and LPS / Dex; p = 0.0048.
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proinflammatory
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